Skip to main content

Table 3 Correlations of genotypes with risks of NAFLD and CHD in the study groups

From: Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population

 

OR (95% CI)

P1

OR (95% CI)

P2

OR (95% CI)

P3

OR (95% CI)

P4

OR (95% CI)

P5

OR (95% CI)

P6

AA + AG

1

0.904

1

0.124

1

0.205

1

0.197

1

0.018

1

0.497

GG

0.963 (0.523–1.774)

0.545 (0.251–1.183)

1.556 (0.786–3.078)

1.615 (0.780–3.346)

2.857 (1.196–6.824)

0.713 (0.268–1.891)

Adjusteda

            

AA + AG

1

0.476

1

0.752

1

0.096

1

0.648

1

0.011

1

0.650

GG

1.285 (0.645–2.560)

0.840 (0.286–2.470)

2.147 (0.874–5.273)

1.236 (0.498–3.066)

3.252 (1.306–8.102)

0.789 (0.284–2.192)

  1. OR odds ratio, CI confidence interval
  2. P1: NAFLD patients vs. healthy controls; P2: CHD patients vs. healthy controls; P3: NAFLD + CHD patients vs. healthy controls; P4: NAFLD patients vs. NAFLD + CHD patients; P5: CHD patients vs. NAFLD + CHD patients; P6: lean NAFLD patients vs. obese NAFLD patients
  3. aBinary logistic regression model was adjusted for age, gender, and BMI